<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study aimed to investigate the role of p38 MAPK phosphorylation and opening of the mitoK(ATP) channels in the <z:chebi fb="0" ids="9130">sevoflurane</z:chebi>-induced delayed neuroprotection in the rat brain </plain></SENT>
<SENT sid="1" pm="."><plain>Adult male Sprague-Dawley rats (250-300 g) were randomly assigned into four groups: <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion (Control), <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> (Sevo), 5-hydroxydecanoate (5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) + <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> (5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> + Sevo) and 5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> groups and were subjected to right middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) for 2 h </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> preconditioning was induced 24 h before MCAO in <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> and 5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> + <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> groups by exposing the animals to 2.4% <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> in oxygen for 60 min </plain></SENT>
<SENT sid="3" pm="."><plain>In control and 5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> groups: animals were exposed to oxygen for 60 min at 24 h before MCAO </plain></SENT>
<SENT sid="4" pm="."><plain>A selective mitoK(ATP) channel <z:chebi fb="68" ids="48706">antagonist</z:chebi>, 5-hydroxydecanoate (5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>, 40 mg/kg, i.p.), was administered 30 min before <z:chebi fb="0" ids="9130">sevoflurane</z:chebi>/oxygen exposure in the 5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> + <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> and 5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> groups, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Neurological deficits scores and the protein expression of phosphorylated p38 <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase (p-p38 MAPK) were evaluated at 24 and 72 h after reperfusion </plain></SENT>
<SENT sid="6" pm="."><plain>Cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> size was evaluated at 72 h after reperfusion by 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> preconditioning produced marked improvement neurological functions and a reduction in brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes than animals with <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> only </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> treatment also caused increased phosphorylation of p38 MAPK at 24 and 72 h after reperfusion </plain></SENT>
<SENT sid="9" pm="."><plain>These beneficial effects were attenuated by 5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Blockade of cerebral protection with 5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> concomitant with decrease in p38 phosphorylation suggests that mitoK(ATP) channels opening and p38 phosphorylation participate signal transduction cascade of <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning and p38 MAPK activation may be a downstream of opening mitoK(ATP) channels </plain></SENT>
</text></document>